Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 14 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Tzilves, Dimitrios [Clear All Filters]
Active Helicobacter pylori infection is associated with colorectal mucosa-adenomatous polyp--early and advanced adenocarcinoma sequence..
Scand J Gastroenterol. 49(3), 381-2.
(2014). Association between Helicobacter pylori infection and fibromyalgia syndrome..
Clin Rheumatol. 30(2), 301-2.
(2011). Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome..
J Neurogastroenterol Motil. 29(3), 403-404.
(2023). Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease..
J Neurol. 256(5), 758-67.
(2009). Helicobacter pylori might be a potential therapeutic target in epilepsy..
Med Hypotheses. 76(5), 763.
(2011). Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors..
Hepatology. 60(4), 1450-1.
(2014). Hpn protein as a mediator between Helicobacter pylori infection and Alzheimer's disease in sub-populations worldwide..
Med Hypotheses. 78(2), 349-50.
(2012). Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence..
Helicobacter. 23(6), e12534.
(2018). Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease..
Int J Neurosci. 119(6), 765-77.
(2009). Letter: higher severe outcomes among Helicobacter pylori-related lean patients with non-alcoholic fatty liver disease and metabolic comorbidities..
Aliment Pharmacol Ther. 57(10), 1186-1187.
(2023). Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia..
Am J Gastroenterol. 106(12), 2204-6.
(2011).
(2011).
(2023).
A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein..
Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
(2012).